跳至主要内容
临床试验/NCT01681875
NCT01681875已完成不适用

Project 1, Study 1: Investigating the Impact of Nicotine Using Spectrum Cigarettes

Wake Forest University Health Sciences18 个研究点 分布在 1 个国家目标入组 839 人开始时间: 2013年6月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
839
试验地点
18
主要终点
Number of cigarettes smoked per day

研究概览

简要总结

Project 1, Study 1 will evaluate the relationship between nicotine yield of very low nicotine content cigarettes and cigarettes smoked per day, nicotine exposure, discomfort/dysfunction, other health-related behaviors, nicotine/tobacco dependence, biomarkers of tobacco exposure, intention to quit, compensatory smoking, other tobacco use, cigarette characteristics, cognitive function, cardiovascular function, and perceived risk. We will also consider differences between conditions in compliance with product use.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Smoke an average of at least five cigarettes per day for at least 1 year
  • Breath CO levels > 8 ppm (if ≤ 8 ppm, then NicAlert Strip > 2)

排除标准

  • Intention to quit smoking in the next 30 days
  • Currently seeking treatment for smoking cessation
  • Currently using nicotine replacement therapies or other pharmacotherapies as cessation aid (intermittent use acceptable)
  • A quit attempt in the past 30 days resulting in greater than 3 days of abstinence
  • Using other tobacco products more than 9 days in the past 30 days
  • Significant unstable medical conditions (Any significant change in a serious medical condition occurring during the past 3 months including, cardiovascular disease, COPD, and cancer, as determined by the licensed medical professional at each site)
  • Significant unstable psychiatric conditions (Any significant change in psychiatric symptoms during the past 3 months as determined by the licensed medical professional at each site)
  • Schizophrenia and schizoaffective disorder
  • Psychiatric medication changes in the past 3 months
  • Positive toxicology screen for any of the following drugs: cocaine, opiates, methadone, benzodiazepines, barbiturates, amphetamines, methamphetamines, and PCP
  • Marijuana will be tested for but will not be an exclusionary criterion.
  • Participants with valid prescriptions for opiates, benzodiazepines, barbiturates, amphetamines or methadone will not be excluded.
  • Participants failing the toxicology screen will be allowed to re-screen once.
  • Blood alcohol level > 0.01
  • a. Participants failing the blood alcohol screen will be allowed to re-screen once.
  • Binge drinking alcohol (more than 9 days in the past 30 days, 4/5 in a 2 hour period(female/male))
  • Pregnant or breastfeeding
  • Smoking 'roll your own cigarettes' exclusively
  • Currently taking anticonvulsant medication
  • CO reading >80 ppm
  • Systolic BP greater than or equal to 160
  • a. Participants failing for blood pressure will be allowed to re-screen once.
  • Diastolic BP greater than or equal to 100
  • a. Participants failing for blood pressure will be allowed to re-screen once.
  • Systolic BP below 90
  • a. Participants failing for blood pressure will be allowed to re-screen once.
  • Diastolic BP below 50
  • a. Participants failing for blood pressure will be allowed to re-screen once.
  • Heart rate greater than or equal to 115bpm
  • a. Participants failing for heart rate will be allowed to re-screen once.
  • Heart rate lower than 45bpm
  • a. Participants failing for heart rate will be allowed to re-screen once.
  • Indicating any suicidal ideation in the past month or suicide attempts in the past 10 years
  • Inability to independently read and comprehend the consent form and other written study materials and measures
  • Having participated in a research study during the past three months in which the participant:
  • Smoked a cigarette that was not his/her usual brand cigarette for more than one day
  • Used any tobacco products beyond normal use for more than one day
  • Used any nicotine replacement products or smoking cessation medications for more than one day

研究组 & 干预措施

0.8 mg nicotine with 9 mg tar

Experimental

very low nicotine content cigarettes

SPECTRUM Cigarette: 0.8 (±0.15) mg nicotine with 9 (±1.5) mg tar (standard nicotine and tar yields of commercially-available cigarettes; control condition)

干预措施: very low nicotine content cigarettes (Other)

0.26 mg nicotine with 9 mg tar

Experimental

very low nicotine content cigarettes

SPECTRUM Cigarette: 0.26 (±0.06) mg nicotine with 9 (±1.5) mg tar

干预措施: very low nicotine content cigarettes (Other)

0.12 mg nicotine with 9 mg tar

Experimental

very low nicotine content cigarettes

SPECTRUM Cigarette: 0.12 (±0.03) mg nicotine with 9 (±1.5) mg tar

干预措施: very low nicotine content cigarettes (Other)

0.07 mg nicotine with 9 mg tar

Experimental

very low nicotine content cigarettes

SPECTRUM Cigarette: 0.07 (±0.02) mg nicotine with 9 (±1.5) mg tar

干预措施: very low nicotine content cigarettes (Other)

0.03 mg nicotine with 9 mg tar

Experimental

very low nicotine content cigarettes

SPECTRUM Cigarette: 0.03 (±0.01) mg nicotine with 9 (±1.5) mg tar

干预措施: very low nicotine content cigarettes (Other)

0.04 mg nicotine with 13 mg tar

Experimental

very low nicotine content cigarettes

SPECTRUM Cigarette: 0.04 (±0.02) mg nicotine with 13 (±2) mg tar

干预措施: very low nicotine content cigarettes (Other)

Usual brand

Other

very low nicotine content cigarettes

Usual brand cigarettes (control condition)

干预措施: very low nicotine content cigarettes (Other)

结局指标

主要结局

Number of cigarettes smoked per day

时间窗: End of 6 week intervention

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (18)

Loading locations...

相似试验

Project 1, Study 1: Investigating the Impact of... | 临床试验